Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 8561892, 13 pages
https://doi.org/10.1155/2018/8561892
Research Article

p66Shc Inactivation Modifies RNS Production, Regulates Sirt3 Activity, and Improves Mitochondrial Homeostasis, Delaying the Aging Process in Mouse Brain

1Laboratory of Oxygen Metabolism, INIGEM-UBA-CONICET, Buenos Aires, Argentina
2Departamento de Medicina, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
3Departamento de Bioquímica Clínica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina

Correspondence should be addressed to María Cecilia Carreras; ra.abu.byff@sarerrac

Received 24 October 2017; Accepted 17 January 2018; Published 12 March 2018

Academic Editor: Tim Hofer

Copyright © 2018 Hernán Pérez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Programmed and damage aging theories have traditionally been conceived as stand-alone schools of thought. However, the p66Shc adaptor protein has demonstrated that aging-regulating genes and reactive oxygen species (ROS) are closely interconnected, since its absence modifies metabolic homeostasis by providing oxidative stress resistance and promoting longevity. p66Shc(−/−) mice are a unique opportunity to further comprehend the bidirectional relationship between redox homeostasis and the imbalance of mitochondrial biogenesis and dynamics during aging. This study shows that brain mitochondria of p66Shc(−/−) aged mice exhibit a reduced alteration of redox balance with a decrease in both ROS generation and its detoxification activity. We also demonstrate a strong link between reactive nitrogen species (RNS) and mitochondrial function, morphology, and biogenesis, where low levels of ONOO formation present in aged p66Shc(−/−) mouse brain prevent protein nitration, delaying the loss of biological functions characteristic of the aging process. Sirt3 modulates age-associated mitochondrial biology and function via lysine deacetylation of target proteins, and we show that its regulation depends on its nitration status and is benefited by the improved NAD+/NADH ratio in aged p66Shc(−/−) brain mitochondria. Low levels of protein nitration and acetylation could cause the metabolic homeostasis maintenance observed during aging in this group, thus increasing its lifespan.

1. Introduction

Aging is a multifactorial degenerative process that strongly impacts the endocrinology and biochemistry of the brain [1]. Mitochondrial function declines in the normal aging process and increases the incidence of age-related disorders. In accordance with the free radical theory of aging, this process can be ascribed to the oxidative damage caused by the generation of reactive oxygen species (ROS) derived from mitochondrial respiration when O2 is partially reduced [2]. It has been demonstrated that electron transfer leakage throughout the mitochondrial respiratory chain is responsible for the formation of most cellular ROS [3]. In this way, ROS generation depends on mitochondrial activity [4], which by itself can be perceived as a signal sensor and transducer in various enzymatic and gene-mediated physiological and pathophysiological processes [5].

In addition, mitochondrial function and morphology are also modulated by nitric oxide (NO) exposure. NO is a relatively low reactive radical whose derivatives, such as peroxynitrite (ONOO), can cause nitrosative damage in biomolecules, proteosomic degradation failure, enzymatic activity inhibition, and overall interference of regulatory functions [6]. These processes occur in aging, when the levels of ROS rise and superoxide anion (O2) conjugates with NO to create reactive nitrogen species (RNS), and their products nitrate (NO3), nitrite (NO2), and peroxynitrite (ONOO), which have demonstrated a direct role in cellular signaling, vasodilation, immune response, and aging [79].

Alterations in ROS/RNS levels have been mechanistically linked with changes in mitochondrial morphology in many studies, suggesting a crosstalk between redox homeostasis and mitochondrial dynamics [10]. Mitochondrial morphology is regulated by continuous fusion and fission events that are essential to maintaining normal mitochondrial function [11]. These fusion/fission processes are finely regulated by the mitochondrial fusion proteins optic atrophy 1 (Opa1), mitofusins 1 and 2 (Mfn1 and Mfn2, resp.) and by the mitochondrial fission proteins dynamin-related protein 1 (Drp1) and fission protein 1 (Fis1). High levels of ROS and RNS, such as those measured in aging models, have been associated with redox-induced posttranslational modifications (i.e., nitration or S-nitrosylation) in several of these proteins and their binding targets, leading to mitochondrial fragmentation [1214].

Mitochondrial plasticity and density decrease with age, and their capacity for mitochondrial biogenesis is reduced owing to a redox-dependent decline of (peroxisome proliferator-activated receptor γ-coactivator-1α) (PGC-1α) activity [1517]. PGC-1α is a transcriptional coactivator that enhances the activity of specific transcription factors, in turn coordinating the expression of key nuclear-encoded mitochondrial genes that are required for the proper functioning of the organelle.

A link between mitochondrial biogenesis and mitochondrial morphology has been suggested by the fact that PGC-1α regulates Mfn2 expression. Repression of Mfn2 in cells decreases oxygen consumption, mitochondrial membrane potential, and the expression of oxidative phosphorylation proteins [17].

On the other hand, changes observed in the lysine acetylation profile of proteins or “acetylome” are related to normal aging and age-related diseases [18]. Sirt3, a member of the NAD+-dependent deacetylase family, is the most studied mitochondrial sirtuin associated with metabolic homeostasis maintenance. Sirt3 is considered a key element to delaying the loss of biological functions during aging [19]. Recent studies have shown that the acetylation levels of mouse mitochondrial proteins are modulated in fasting conditions or during caloric restriction [20]. Additionally, an increase in Sirt3 expression was observed in several tissues under these conditions, suggesting an improvement in the protection against ROS-induced aging [2124]. SIRT3 stimulates proteins participating in ATP generation, tricarboxylic acid (TCA) cycle, and electron transport chain and stress response [25, 26]. Further, it promotes mitochondrial biogenesis via PGC-1α-mediated inhibition of cellular ROS and delays mitochondrial dynamic age imbalance, deacetylating Opa1 [27, 28].

In the last years, more cases of cooperation between ROS and aging-regulating genes have been established in senescence and aging development [29]. The adaptor protein p66Shc is a genetic determinant of lifespan that regulates ROS metabolism and cellular apoptosis. Faced with a stress signal (growth factor, insulin receptor activation, excessive radiation, or oxidative stress), PKCβ phosphorylates p66Shc in Ser36, which translocates to mitochondria, oxidizes cytochrome c in the intermembrane space, and prevents electron transfer to cytochrome oxidase, resulting in a higher reduction level of complex III (ubiquinol and cytochromes b-c1) [30]. The inhibition of electron free flow determines the formation of semiubiquinone and the subsequent O2 monoelectric reduction with O2 formation, eventually dismutated to hydrogen peroxide (H2O2) by MnSOD [31]. p66Shc ablation in mice is translated into a significant decrease in mitochondria-produced ROS and a 30% increase in lifespan [32]. These knockout mice for p66Shc (p66Shc(−/−)) have been shown to be thinner, to exhibit an increased metabolic rate, and to have less body fat than their wild-type littermates [33]. And more remarkably, they have been described as an animal model of healthy aging with better cognitive abilities at adulthood in a spatial memory task and improved physical performance at senescence [34]. The aim of this study is to deepen the bidirectional relationship between redox homeostasis and the imbalance of mitochondrial dynamics and biogenesis in this model of healthy aging.

2. Materials and Methods

2.1. Mice and Ethics

Dr. P. G. Pellicci at the European Institute of Oncology, Milan, kindly provided 129 p66Shc knockout (p66Shc(−/−)) breeding pairs for this project. The breeding stocks were backcrossed onto 129/SV mice. A colony was maintained in the animal facility at the School of Pharmacy and Biochemistry of the University of Buenos Aires. Heterozygous Shc KO mice (p66Shc(+/−)) were mated to produce the homozygous Shc KO (p66Shc(−/−)), and WT control littermates were used for the study. Mice aged 3, 18, and 24 months from both groups were housed in a constant-temperature room (20–24°C) with a 12-hour dark/12-hour light cycle, fed ad libitum with a standard diet and free access to water. Animal experiments were performed in accordance with the principles of laboratory animal care. The Institutional Animal Care and Research Committee of the University of Buenos Aires approved all animal procedures. We made every possible effort to minimize animal suffering and to reduce the number of animals used.

2.2. Mitochondrial Isolation

Mice were deeply anesthetized using ketamine (50 mg/kg) and sacrificed by cervical dislocation. The brains were immediately extracted and homogenized in MSHE buffer (0.22 M mannitol, 70 mM sucrose, 0.5 mM EGTA, 2 mM KHEPES). The homogenate was centrifuged at 800 for 10 min at 4°C. The supernatant was transferred and centrifuged again at 10,000 for 10 min at 4°C in a Sorvall centrifuge. The pellet containing mitochondria was resuspended and isolated at 100,000 by Percoll gradient centrifugation in an ultracentrifuge [35]. Fresh mitochondria were used to determine membrane potential, oxygen consumption, NO production, nNOS activity, and NAD/NADH ratio. For complex activities, MnSOD and catalase activity, and Western blotting determination, mitochondria were stored at −80°C and then subjected to three freeze/thaw cycles followed by a homogenization step by passage through a 29 G hypodermic needle.

2.3. NOS Activity

Homogenate fractions of brain tissue from control and KO (p66Shc−/−) mice were determined by conversion from [3H] L-Arg to [3H] L-citrulline [36] in 50 mM potassium phosphate buffer, pH 7.4, in the presence of 100 μM L-Arg, 0.1 μM [3H] L-Arg (NEN), 0.1 mM NADPH, 0.3 mM CaCl2, 0.1 μM calmodulin, 10 μM tetrahydrobiopterin, 1 μM flavin adenine dinucleotide, 1 μM flavin mononucleotide, 50 mM L-valine, and 1 mg/mL protein. Specific activity was calculated by subtracting the remaining activity in the presence of the NOS inhibitor 5 mM L-NMMA or 2 mM ethylene glycol tetraacetic acid [37].

2.4. Mitochondrial H2O2 Production

Mitochondrial H2O2 production was monitored using a Hitachi F-2000 spectrofluorometer with excitation and emission wavelengths at 315 and 425 nm, respectively [31]. The reaction medium, potassium phosphate buffer (50 mM) and 50 mM L-valine, was supplemented with 10 mM succinate, 12.5 units/mL horseradish peroxidase, 250 M p-hydroxyphenylacetic acid, and 0.15 mg of mitochondrial protein per mL. Mitochondrial preparations were supplemented with 1 μM Mn(III)tetrakis(4-benzoic acid) porphyrin (Cayman Chemical, Ann Arbor, MI) and 0.2 μM antimycin A for a uniform maximal H2O2 production rate [38].

2.5. Antioxidant Enzyme Activities

Mitochondrial Mn-SOD activity was determined by inhibition of cytochrome c reduction at 550 nm in 50 mM potassium phosphate buffer/0.1 mM EDTA (pH 7.8) at 25°C, and results were expressed as pmoles SOD per mg of protein [39]. Catalase activity in supernatants was determined by the decrease in H2O2 absorption at 240 nm (). The pseudo-first reaction constant () expressed as /mg protein was calculated and then extrapolated to a calibration curve to obtain U CAT/mg protein [40].

2.6. Oxygen Consumption Rate

Oxygen uptake was determined polarographically with a Clark-type electrode placed in a 3 mL chamber at 30°C, in a reaction medium consisting of 0.23 mM mannitol, 70 mM sucrose, 30 mM Tris-HCl, 4 mM MgCl2, 5 mM Na2HPO4-KH2PO4, and 1 mM EDTA, pH 7.4, saturated with room air (225 μM O2) with 0.5–1 mg mitochondria protein/mL. Oxygen uptake was determined using 6 mM malate-glutamate or succinate as substrates in the presence (state 3) or the absence (state 4) of a phosphate acceptor (0.2 mM ADP). Oxygen uptake was expressed in nanogram atoms of oxygen per minute per milligram of protein. The respiratory control rate was calculated as state 3/state 4 respiration rate. The P/O ratio was calculated as the ratio of nmoles of added ADP per nanogram atoms of O2 utilized during state 3 [41, 42].

2.7. Mitochondrial Respiratory Chain Complex Activity

Nicotinamide adenine dinucleotide- and succinate-cytochrome c reductase activities (complexes I–III and II–III, resp.) were assayed by cytochrome c reduction at 550 nm with a Hitachi U3000 spectrophotometer (Hitachi, Tokyo, Japan) at 30°C. Cytochrome oxidase activity (complex IV) was determined by monitoring cytochrome c oxidation at 550 nm (); the reaction rate was measured as the pseudo-first-order reaction constant () and expressed as /min/mg protein [43].

2.8. Mitochondrial Membrane Potential (Ψ) and Mitochondrial NO, ROS, and O2 Production

Mitochondrial membrane potential (Ψ) and mitochondrial NO, ROS, and O2 production were estimated by flow cytometry (FACSCalibur) using fluorescent dyes 3,3-dihexyloxacarbocyanine iodide (DiOC6) (200 nM; Molecular Probes), DAF-FM (10 μM; Molecular Probes) with 0.3 mM L-arginine in the presence and absence of the NOS inhibitor (3 mM L-NAME), H2DCFDA (25 μM; Sigma-Aldrich), or MitoSOX (2.5 μM; Molecular Probes), respectively. Fresh brain mitochondria (50 μg protein/mL) were suspended in 0.5 mL of respiration buffer (120 mM KCl, 5 mM KH2PO4, 1 mM EGTA, 3 mM HEPES, and 1 mg/mL fatty acid-free BSA [pH 7.4]). These assays were performed in the dark at 37°C for 15 min. After the incubation period, mitochondria were centrifuged for 5 min at 10,000 for pelleting and washing and then suspended to record the fluorescence intensity.

2.9. NAD/NADH Mitochondrial Ratio and ATP Content

The NAD Cycling Enzyme Mix in Abcam NADH/NAD Quantification Kit was specifically used to recognize NADH/NAD+ in an enzyme cycling colorimetric reaction read at OD 450 nm in a colorimetric microplate reader. Total ATP content was determined in 10 mg of fresh slice brain tissue based on luciferase’s requirement for ATP in producing light (emission maximum ~560 nm at pH 7.8) using the ATP bioluminescent assay kit (Molecular Probes).

2.10. SIRT3 Deacetylase Activity

SIRT3 deacetylase activity was determined as described in Cayman’s SIRT3 direct fluorescent screening assay kit (item no. 10011566). In a plate, assay buffer, modified p53 acetylated peptide, recombinant Sirt3, and NAD+ were incubated with increased concentrations of ONOO (100, 250, and 500 μM) or with purified mitochondrial lysates, final volume 50 μL. Deacetylation reactions were stopped after 2 h of incubation at room temperature by adding 50 μL of stop solution. The fluorophore release by deacetylation of the p53 peptide was analyzed with a fluorometer using an excitation wavelength of 350–360 nm and an emission wavelength of 450–465 nm [44].

2.11. Mitochondrial Morphology

Transmission electron microscopy was performed in 90 nm sections from mouse brains and fixed in 4% paraformaldehyde, 2% glutaraldehyde, and 5% sucrose in PBS, followed by 2 h postfixation in 1% osmium tetroxide and then 1 h in uranyl acetate in 50% ethanol. Samples were washed with 50% ethanol and dehydrated with a graded series of ethanol, clarified with acetone, and embedded in Vestopal. Grids were prepared and stained with uranyl acetate and lead citrate. Samples were observed at 100 kV with a Zeiss EM 109T transmission electron microscope (Zeiss, Oberkochen, Germany). The mitochondrial area and length were measured in 400 mitochondria per mouse using the ImageJ software. For the quantification of mitochondrial morphology, we used the criteria described in [45].

2.12. RNA Extraction, Quantitative Real-Time PCR, and mtDNA Content

Total RNA was extracted with TRIzol Reagent (Invitrogen Corp.). After DNase treatment, 2 μg of samples was reverse-transcribed in duplicate using Taq polymerase and Oligo d(T)16. For RT-qPCR studies, cDNA samples were diluted 5-fold, and for mtDNA/nDNA qPCRs, 40 ng of total genomic DNA was used. PCR amplification and analyses were performed with StepOnePlus Real-Time PCR Systems (Thermo Fisher). SYBR® Green PCR Master Mix (Thermo Fisher) was used for all reactions, following the manufacturer’s instructions. Total DNA was precipitated with isopropanol (vol. 1 : 1) from brain tissue samples (∼10 mg), homogenized in 20 mg/mL of proteinase K solution, and finally dissolved in Tris-EDTA buffer. The mtDNA/nDNA ratio was calculated using mtDNA primers for the 16S rRNA and nDNA primers for the β-2 microglobulin (β2M) gene [46].

2.13. Western Blots

15 to 70 μg of protein was electrophoresed on 10–15% vol/vol polyacrylamide SDS-PAGE gels. Proteins were electrophoretically transferred onto PVDF membranes. The membranes were subsequently blocked and, after blocking, were incubated at room temperature with the following antibodies: 1 : 500 anti-NOS1 (R-20) : sc-648, 1 : 500 anti-Mfn2 (H-68) : sc-50331, 1 : 2000 anti-actin (I-19) : sc-1616, and 1 : 2000 anti-VDAC1 (N-18) : sc-8828 were obtained from Santa Cruz, CA. 1 : 500 anti-OPA1 : 612607 and 1 : 1000 anti-DLP1 : 611113 were obtained from BD Biosciences. 1 : 1000 anti-phospho-DRP1 (Ser616) : #3455 was obtained from Cell Signaling. 1 : 1000 anti-nitrotyrosine, clone1A6 : #05-233 was obtained from EMD Millipore.

2.14. Coimmunoprecipitation

Mitochondrial proteins (500 μg) were incubated with 4 μg of monoclonal anti-Sirt3 antibody (C73E3) and 30 μL protein A/G PLUS Agarose (Santa Cruz, CA) at 4°C. The beads were then washed three times, suspended in sample buffer, boiled, and centrifuged, and the supernatants were subjected to immunoblotting against monoclonal anti-Sirt3 or anti-nitrotyrosine, clone1A6, antibodies.

2.15. Statistical Analyses

Statistical analyses were performed using GraphPad Prism 5.01. Data are presented as , and significant differences between groups were assessed using one-way analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison test or Dunnett’s test [47].

3. Results

3.1. Oxidative Characteristics and ROS Production of Isolated Brain Mitochondria Are Inversely Modified in WT and p66Shc(−/−) Aged Mice

Aiming at understanding how p66Shc participates in the redox homeostasis balance in aging, several biochemical techniques were used to determine different oxidative parameters in purified brain mitochondria from young (3-month-old) and old (24-month-old) WT and p66Shc−/− mice. As shown in Table 1A, there was a significant increment in H2O2 production by WT mice during aging. This increase in the production rate varied based on the use of malate-glutamate or succinate as the electron transport chain (ETC) substrate, being 33% and 25%, respectively (). In turn, p66Shc−/− mice exhibited a significant reduction in total mitochondrial H2O2 production with both substrates when compared to WT mice (41% and 26%, resp., ) within the aged mouse groups. Concomitantly, superoxide generation (O2) and ROS production rate, measured with MitoSOX and H2DCFDA, increased steeply in the WT group during aging (92% and 46%, resp., ) while in aged KO mice a slight rise was observed in comparison to the young WT control group (38% and 8%, resp., ) (Table 1B and C).

Table 1: Oxidative parameters in isolated brain mitochondria of wild-type and p66Shc(−/−) aged mice.

On the other hand, when the antioxidant detoxification response was analyzed, our results showed that the loss of MnSOD enzymatic activity registered in aging was more pronounced in WT mice than in the aged KO group when contrasted to the 3-month-old WT control (19% and 13%, resp., ). No changes were observed in catalase activity (Table 1D and E). No differences were detected in any parameters between WT and p66Shc−/− young mouse groups (data not shown).

3.2. nNOS Activity and RNS Production Are Altered in Old Transgenic p66Shc(−/−) Mice

Considering the low levels of ROS production in p66Shc(−/−) aged mice and its key role in RNS formation during aging, it was interesting to assess how the levels of the nNOS enzyme, and its products and byproducts, were modified in old p66Shc(−/−) mouse brains. The absence of p66Shc did not affect nNOS gene transcription or protein levels in the lifespan of mice. Figure 1(a) shows a significant increase in nNOS activity of p66Shc(−/−) mice during the latest stage of life compared to WT mice (). However, a not significant increase in nNOS content was observed in both groups during aging by Western blot and real-time PCR (Figure 1(b)). In turn, the increase in nNOS activity registered at 24 mo observed in KO mice correlates with the higher NO content measured at the same period () (Figure 1(c)). Interestingly, aged p66Shc−/− mice did not exhibit the same mitochondrial protein nitration profile as aged WT mice did. The latest showed an increment of nitrated proteins compared to the KO group () (Figure 1(d)), consistent with the reduction in H2O2 and O2 production, which is necessary for the reaction with NO to form ONOO.

Figure 1: nNOS expression and RNS production in p66Shc(−/−) brain mice during aging. Mice were sacrificed at 3, 18, and 24 months of age. (a) Time course of nNOS activity in mitochondria brain mice measured by 3H-L-citrulline formation (). (b) RT-qPCR and immunoblot of proteins separated using SDS-PAGE from whole brain lysate reveals nNOS mRNA levels and protein expression of mouse brain in WT (grey) and p66Shc(−/−) (black) groups at 3 and 24 months of age. GADPH mRNA levels and actin protein expression were used as housekeeping control and loading control, respectively (, for each experimental group). (c) NO levels were obtained from 50 μg/mL of isolated mitochondria incubated with 0.3 mM L-arginine, 10 μM DAF-FM, and 0.5 μM MitoTracker (per duplicate) at 495 nm (excitation) and 515 nm (emission) in the presence or absence of the NOS inhibitor (3 mM L-NAME) from (). (d) Western blot of nitrated proteins from the different groups; membranes were revealed with anti-3-nitrotyrosine antibodies for each group (). Values represent error of the mean (SEM); A represents compared to the 3-month-old group, and B represents between 24-month-old WT and p66Shc(−/−) groups, one-way analysis of variance (ANOVA) and Bonferroni post hoc test.
3.3. Altered ROS and RNS in p66Shc KO Mice Modify Brain Mitochondrial Metabolic Parameters in Aging

To understand the effect of RNS and ROS imbalance on the mitochondrial function of aged p66Shc(−/−) mice, isolated and purified brain mitochondria from both groups were used to assess oxygen consumption in ADP stimulation (stage 3) and resting (stage 4) stages. This allowed the determination of the respiratory control ratio (). Table 2 shows the bioenergetics status measured in brain mitochondria, with malate/glutamate or succinate as oxidizable substrate. Aging decreased the oxygen consumption rate by 25% in stage 3 regardless of the substrate used for the WT group (). However, using Mal/Glut as substrate, stage 3 of the respiratory rate was increased by 22% and 68% in aged p66Shc(−/−) mice when compared to the 3-month-old and 24-month-old WT groups, respectively (). Meanwhile, this effect decreased by using succinate as substrate with no differences observed between the aged KO and young WT groups and only a 30% increment between the aged KO and the aged WT groups (). The respiratory control rates using both Mal/Glut and succinate exhibited an approximate 30% inhibition in aging (). In turn, 24-month-old KO mice maintained RCR values similar to those in 3-month-old WT mice (Table 2A). These data suggested an inhibitory effect on the respiratory chain by p66Shc in aged WT mouse brain.

Table 2: Bioenergetic parameters of isolated brain mitochondria of wild-type and p66Shc(−/−) aged mice.

To explain this increase in oxygen consumption rate, the enzymatic activity of the mitochondrial respiratory chain complexes was studied. Results showed that 24-month-old WT mice displayed a higher decrease (48%) in complex I (CI) activity than did aged p66Shc(−/−) mice (34%) when compared to the 3-month-old WT control group () (Table 2). Such decrease in CI activity between the aged groups was noticeable only in the latest stage of life while no differences were observed between the genotypes in previous stages of life (data not shown). Opposite to CI, higher NO concentrations, such as the one observed in p66Shc(−/−) old mice, could be partially responsible for the greater CIV reversible inhibition shown in 24-month-old p66Shc(−/−) mice (31%) in comparison with the decrease observed in WT aging mice (17%) (). No differences were observed in CII–III activity profiles during aging between both genotypes (Table 2B).

Table 2C also shows a decrease in brain tissue ATP content for the aged WT group (65%), although such effect was only partially reverted in aged p66Shc(−/−) mice (35%) (). This was extensive to other bioenergetics parameters. When we analyzed the NAD+/NADH ratio, p66Shc(−/−) mice exhibited a milder decrease (32%) in comparison to the 78% reduction observed in the WT group during aging while the mitochondrial membrane potential (∆Ψ) showed a 14% decrease compared to the 49% decline observed in the same group () (Table 2D and E). Taken together, these results indicate that aged p66Shc(−/−) mice displayed a better mitochondrial function condition compared than aged WT did.

3.4. Mitochondrial Content, Ultrastructure, and Morphology Are Modified in Aged p66Shc(−/−) Mouse Brain

Based on the improved bioenergetics parameters observed in p66Shc(−/−) mice and the already accepted downregulated mitochondrial biogenesis in aging, it is interesting to study how p66Shc impacts on mitochondrial quantity and structure. The mitochondrial content of a sample can be determined using different methods that provide information about mitochondrial biogenesis and tissue’s oxidative capacity. Mitochondrial DNA (mtDNA) content relative to nuclear DNA was determined by real-time qPCR in brain samples of the study groups and shown as a percentage of the 3-month-old WT relative mtDNA content. During aging, mitochondrial content was reduced by 30% in the WT group, while in the p66Shc(−/−) group, a 45% increase was observed () (Figure 2(a)).

Figure 2: Effects of aging on mitochondrial content, biogenesis, and structure in p66Shc(−/−) mouse brain. (a) Quantification of mtDNA and nuclear DNA by qPCR. (b) The mtDNA/nDNA ratio was calculated from 3- and 24-month WT (grey) and p66Shc(−/−) (black) groups. The mRNA levels of PGC-1α were measured in TRIzol-treated brain extracts from all the studied groups; GADPH mRNA was used as standard (). (c) Mitochondrial morphology was evaluated using electron microscopy of fixed brain slices ( for each experimental group) (magnification:×20,000). (d) At least 300 tubular and fragmented mitochondria were counted per arbitrary area. The percentage distribution of tubular and fragmented brain mitochondria was determined in a minimum of 8–10 random fields at ×4400 magnification to ensure a representative area of analysis (). Mitochondria whose length was more than three times their width were considered tubular, while the remaining round mitochondria were considered fragmented. The analysis was performed by two different investigators in a blinded fashion. Values represent the ; A represents compared to the 3-month-old group, B represents between 24-month-old WT and p66Shc(−/−) groups, one-way analysis of variance (ANOVA) and Bonferroni post hoc test.

In accordance with these results, the PGC-1α mRNA expression level declined by 50% in WT mouse brains during aging, whereas in the p66Shc(−/−) group, PGC-1α remained stable through their lives () (Figure 2(b)). Electron microscope images with fresh brain slices showed differences in mitochondrial morphology (Figure 2(c)). For both WT and p66Shc(−/−) 3-month-old mice, normal size and volume mitochondria were observed, with predominantly tubular-shaped mitochondria (70% of total measured mitochondria), while the remaining displayed round (fragmented) morphology. However, at the end of their life, the time point of maximal ROS production, 24-month-old WT mouse brain slices were characterized by decreased tubular mitochondria (−44%) and increased round-shaped mitochondria (+120%) (). This age effect in mitochondrial morphology was partially mitigated in 24-month-old p66Shc(−/−) mice, to the extent that both types of mitochondrial populations coexisted in this group (55% tubular mitochondria) showing an intermediate phenotype between 3- and 24-month-old WT mice () (Figure 2(d)).

3.5. The Absence of p66Shc Is Associated with Changes in Mitochondrial Dynamics in Aging

Mitochondrial morphology depends on the interaction among highly dynamic processes, such as the fusion/fission balance. To understand how p66Shc intervenes in mitochondrial dynamics, we analyzed changes in some of the main proteins responsible for the mitochondrial network remodeling. Figure 3(a) shows that in WT mice, the Mfn2 fusion protein content in the mitochondrial fraction decreased with aging (30%), while p66Shc(−/−) mice exhibited a rise in the levels of this protein (25%) (). Additionally, Mfn2 mRNA levels during aging remained steady in the WT genotype while the KO group presented a rising tendency which became significant for the 24-month-old group (3-fold increase of control) () (Figure 3(a)). Unlike Mfn2, no differences were registered either in the Opa1 levels in the mitochondrial fraction of the same tissue or in its messenger expression (Figure 3(b)). To further comprehend the effect of p66 in the mitochondrial network, we also studied a mitochondrial fission dynamin-related protein (Drp1). This protein was downregulated (30%) in KO mice during the latest stages of life, while in the WT group an upregulation of Drp1 was observed during aging (50%) (). An increase in p-Drp1 (S616) levels is shown in WT mice throughout their lives (2.5-fold) (). However, no changes were detected on p-Drp1 (S616) content in p66Shc(−/−) mouse brain during aging (Figure 3(c)). The pattern observed in Drp1 protein levels throughout the lives of both WT and p66Shc(−/−) mouse groups was similar to that of their gene expression, exhibiting a rise in aged WT mouse brain (3-fold) and remaining stable in the p66Shc(−/−) group, as shown in the same figure ().

Figure 3: Effects of aging on mitochondrial dynamics in p66Shc(−/−) mouse brain. Immunoblot of proteins separated using SDS-PAGE from purified brain mitochondria or whole brain lysate and RT-qPCR of mRNA from TRIzol-treated brain extracts were performed. The expression of the fusion proteins Mfn2 (a) and Opa1 (b), and the fission protein Drp1 (c) with its (S616) phosphorylated active isoform and mRNA levels of mouse brain in WT (grey) and p66Shc(−/−) (black) groups were observed at 3, 18, and 24 months of age. VDAC protein expression in mitochondrial fraction, actin protein expression in whole brain lysates, and GADPH mRNA levels in RT-qPCR were used as standard, respectively (, for each experimental group). Values represent the ; A represents compared to the 3-month-old group, B represents between 18- or 24-month-old WT and p66Shc(−/−) respective groups, one-way analysis of variance (ANOVA) and Bonferroni post hoc test.
3.6. Sirt3 Activity Is Sensitive to Being Downregulated by Nitration

To further comprehend how the high levels of RNS, more precisely ONOO, can modulate the deacetylating capacity of mitochondria, we studied the biochemistry of Sirt3, which is the main protein responsible for this process in this organelle. Its biological activity depends on NAD as a cofactor which increased in old p66Shc(−/−) mice (Table 2D). Using the bioinformatics software GPS (Group-Based Prediction System), which allowed us to predict different posttranslational modifications, we analyzed the murine aminoacidic sequence of Sirt3 deacetylase and detected a tyrosine susceptible to be nitrated at position 100. Such position has been reported to be a part of the NAD-binding domain. With the use of a commercial kit, we tested if Sirt3 activity was sensitive to nitration. Incubating a recombinant Sirt3 (rSirt3) with increasing concentrations of ONOO (100, 250, and 500 μM), we observed a decrease in the enzymatic activity by 47%, 55%, and 70%, respectively () (Figure 4(a)). Furthermore, the 3-nitrotyrosine content of the Sirt3 protein immunoprecipitated from purified mitochondria showed a higher increase on Sirt3 nitration in the WT group compared to the p66Shc(−/−) group during aging. No age- or genotype-related differences were observed in the Sirt3 expression levels measured by immunoprecipitation assay with anti-Sirt3 antibodies (Figure 4(b)). In agreement with these results, rSirt3 activity in the presence of the mitochondrial fraction from aged p66Shc(−/−) mouse brain was higher than that observed when challenged with the aged WT mitochondrial fraction (). This inhibitory effect was equivalent to the one obtained with 100 μM ONOO incubation, while aged p66Shc(−/−) mitochondria with increased NAD/NADH ratio and reduced mitochondrial protein nitration content showed a favorable and less inhibitory environment for rSirt3 activity (33%) () (Figure 4(c)).

Figure 4: Effect of ONOO in Sirt3 activity. Recombinant Sirt3 (rSirt3) activity was examined using a fluorometric method. Assays were performed according to the manufacturer’s instructions. (a) Recombinant Sirt3 (rSirt3) was incubated with increased concentrations of ONOO (100, 250, and 500 μM). (b) Immunoprecipitation of Sirt3 was performed from mitochondrial brain lysates incubated with monoclonal anti-Sirt3 antibody and protein A/G PLUS Agarose and then were subjected to immunoblotting against monoclonal anti-Sirt3 or anti-3-nitrotyrosine antibodies. (c) rSirt3 was incubated with 100 μM ONOO or purified brain mitochondrial lysates from 3- and 24-month WT (grey) and p66Shc(−/−) (black) groups (, for each experimental group). Results were contrasted in pairs between rSirt3 and the two aged groups (a) as well as between both the 24-month-old WT and p66Shc(−/−) groups (b). Values represent ; A and B represent , one-way analysis of variance (ANOVA) and Bonferroni post hoc test.

4. Discussion

Mitochondria play a key role maintaining cellular metabolic homeostasis during aging [48]. In this study, we show that brain mitochondria of p66Shc(−/−) aged mice exhibit a reduced alteration of redox balance and a strong link between reactive nitrogen species and mitochondrial function, morphology, and biogenesis [49]. We also demonstrate that sirtuin 3 lysine deacetylase activity is modulated by its nitration status and is enhanced by the improved NAD+/NADH ratio observed in aged p66Shc(−/−) brain mitochondria.

Brain mitochondria of p66Shc(−/−) aged mice exhibit a reduced alteration of redox balance with a decrease both in ROS generation and in its detoxification activity (Table 1), with this balance being the major determinant of lifespan according to Harman’s theory of aging. Although this reduction in the antioxidant response is unexpected, the upregulation of this compensatory mechanism might not be necessary considering this low ROS production condition. Young p66Shc−/− mouse brains show normal baseline levels of intracellular oxidative stress compared to wild types, and other groups reported the upregulation of brain p66-Shc gene expression during aging [50]. These findings can explain the reduced age-related oxidative stress levels observed in p66Shc−/− mice. Therefore, p66Shc can be considered a convergent point between both oxidative stress and programmed genetic theories of aging.

Considerable efforts had been made to understand and explain the effects of oxidants (ROS and RNS) on the resultant oxidative-nitrosative stress on lipids, proteins, and DNA and their contribution to the aging process. During the last years, different groups including ours confirmed that NO is a typical mitochondrial modulator. High levels are harmful and end in protein oxidation and nitration, leading to loss of mitochondrial and cell function, while controlled levels can induce stress resistance and mitochondrial biogenesis [51]. Considering that mitochondrial NO metabolism involves regulatory aspects of ROS production, RNS markedly contribute to the mitochondrial modulation of life processes [52]. Indeed, a significant nNOS increase in rat brain during aging has been recently proven to correlate with an increase in mitochondrial protein nitration [8]. Our findings show an intensification in nNOS activity and high levels of NO in p66Shc(−/−) mouse brain during aging (Figure 1). However, the rise in NO production is not followed by protein nitration. A similar effect was previously shown in p66Shc(−/−) mice, which are protected against age-related endothelial dysfunction due to the increment of NO bioavailability without protein nitration [53]. This remarkable effect observed in aged p66Shc(−/−) mice could also be caused by their lower H2O2 and O2 levels, disfavoring the formation of ONOO by NO breakdown.

Prior evidence has reported a back-and-forth communication flow between changes in ROS/RNS balance and mitochondrial biogenesis, dynamics, and function [10, 54, 55]. This study displays a minor decrease in the respiratory chain complex I (CI) activity with increased oxygen consumption and ATP content in p66Shc(−/−) compared to WT mouse brain during aging, possibly caused by the irreversible nitration of CI at high ONOO concentrations observed in the last ones (Table 2) [49]. Meanwhile, the inhibition of cytochrome c oxidase (CIV) observed in p66Shc(−/−) brain mitochondria, possibly due to the high levels of steady-state matrix NO concentration, is not enough to counteract this improvement in mitochondrial bioenergetics. Even though NO binds to and reversibly inhibits cytochrome c oxidase-modulating respiration, CI would own the highest level of control in brain mitochondria ETC [56].

Sirt3 is part of the mitochondria-localized sirtuins, modulating acetylation of many proteins that participate in redox regulation [21, 22]. One of the most interesting attributes of Sirt3 is its potential to promote the extension of lifespan [57, 58]. Even though the molecular basis for lifespan extension is not yet clear, the upregulation of Sirt3 expression in long-lived individuals and its physical interaction inside mitochondria with proteins related to the aging process, such as FOXO3a or acetyl-coA synthetase (AceCS2), have been indeed previously studied in literature. The FOXO family transcription factors are human homologs of the daf-16 gene in Caenorhabditis elegans, which contributes to the regulation of the nematode lifespan [22]. Additionally, the Sirt3/AceCS2 complex has a role in apoptosis and growth regulation under certain environmental conditions in a specific type of noncancer epithelial cells [59].

Sirt3/PGC-1α decreased oxidative stress and conferred resistance to oxidative stress-induced damage by regulating antioxidant defense [60]. In aging, the gradual decline in mitochondrial content results from an age-dependent reduction of the PGC-1α level, a key regulator of mitochondrial biogenesis [61, 62]. SIRT3 mediates the reduction of the ROS level by stimulating PGC-1α gene expression, and in turn, PGC-1α induces SIRT3 expression, creating a positive-feedback loop [27]. Aged p66Shc(−/−) mice show high levels of PGC-1α gene expression and increased mitochondrial content compared with their WT littermates (Figure 2). Accordingly, an impaired balance between fission and fusion events may also be related to an age-dependent decline in mitochondrial biogenesis [63].

Mitochondrial morphology depends on the interaction of highly dynamic processes, such as the fusion/fission balance. In aging, given the loss of plasticity of these processes, the maintenance of metabolic homeostasis is compromised. It has been described that ROS-induced mitochondrial depolarization might be responsible for mitochondrial fragmentation [64]. In this work, aged p66Shc(−/−) mouse brain mitochondria present enhanced ∆Ψ and display filament or tubular shape. This is consistent with the observed Mfn2 upregulation, a GTPase embedded in the mitochondria outer membrane directly involved in its fusion, and with the downregulation of Drp1 expression (Figure 3), a GTPase that generates ring-like structures constricting mitochondria in fission events. Phosphorylation of Drp1 at Ser 616 (S616) by several kinases including the cyclin-dependent kinase (CDK) family promotes mitochondrial fission [65]. We also observe high levels of pDrp1-S616 in WT mouse brains during aging. These findings suggest an intimate relationship between mitochondrial energetic status and dynamics. Moreover, regulation of these GTPase proteins by posttranslational modification, such as deacetylation by Sirt3 or nitrosylation/nitration by RNS, is extensively described in literature [15, 28].

Interestingly, the utilization of a GPS algorithm predicts the existence of a tyrosine in position 100 of a Sirt3 murine sequence which, as part of the described NAD+-binding domain, is capable of being nitrated [66]. It is known that the decline in NAD+ level during aging disrupts nuclear-mitochondrial communication [67]. However, the level of NAD+ remains stable in p66Shc(−/−) mice throughout their lives. In accordance to these data, we show here that Sirt3 is sensitive to be nitrated and its activity is protected against age-related nitration in brains of aged p66Shc(−/−) mice (Figure 4). These findings suggest a close relationship between RNS and deacetylation activity in brain mitochondria.

In accordance to the free radical theory of aging, this process is triggered and sustained by the deleterious accumulative effect of oxidative damage caused by mitochondrial respiration-generated ROS. On the other hand, the genetic programmed theory asserts that aging and death are necessary parts of evolution, and the low variability in lifespan within species proves that aging is not only a wear-and-tear process [6872]. Through its capacity to generate hydrogen peroxide (H2O2), p66Shc is a clear example of this strong link between oxidative stress and the genetic of aging, and it could be a potential target for anti-aging strategy. The modulation of p66Shc activity could be a candidate for therapeutic intervention for a longer lifespan or higher quality of life.

5. Conclusions

In conclusion, results show the pivotal role of p66Shc inactivation in multiple processes related to aging in mouse brains. Through the modification in ROS/RNS production, which in turn regulates Sirt3 activity, the absence of p66Shc improves mitochondrial dynamics and biogenesis. Taken together, these findings can partially explain the observed delay in the aging of p66Shc(−/−) mouse brains. Moreover, the enhancement in mitochondrial homeostasis can be the underlying cause of the improved cognition and motor function observed in p66Shc KO mice during aging [34]. More studies will still be necessary to fully understand this complex and multifactorial process.

Disclosure

Preliminary data were presented at the LXI Reunión Anual de la Sociedad Argentina de Investigación Clínica, Mar del Plata, Argentina [49].

Conflicts of Interest

The authors declare that they have no conflict of interest.

Acknowledgments

This work was supported by the Agencia Nacional de Promoción Científica y Tecnológica (FONCyT, Grant PICT 02418) and Universidad de Buenos Aires (UBACyT 20020130100574BA).

References

  1. N. A. Bishop, T. Lu, and B. A. Yankner, “Neural mechanisms of ageing and cognitive decline,” Nature, vol. 464, no. 7288, pp. 529–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of Gerontology, vol. 11, no. 3, pp. 298–300, 1956. View at Publisher · View at Google Scholar
  3. M. P. Murphy, “How mitochondria produce reactive oxygen species,” Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. L. Hoffman and P. S. Brookes, “Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions,” Journal of Biological Chemistry, vol. 284, no. 24, pp. 16236–16245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. M. Cerqueira, F. M. Cunha, F. R. M. Laurindo, and A. J. Kowaltowski, “Calorie restriction increases cerebral mitochondrial respiratory capacity in a NO•-mediated mechanism: impact on neuronal survival,” Free Radical Biology & Medicine, vol. 52, no. 7, pp. 1236–1241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Knott and E. Bossy-Wetzel, “Impact of nitric oxide on metabolism in health and age-related disease,” Diabetes, Obesity and Metabolism, vol. 12, Supplement 2, pp. 126–133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. Poderoso, C. Lisdero, F. Schöpfer et al., “The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol,” Journal of Biological Chemistry, vol. 274, no. 53, pp. 37709–37716, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Y. Lam, F. Yin, R. T. Hamilton, A. Boveris, and E. Cadenas, “Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production,” Free Radical Research, vol. 43, no. 5, pp. 431–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. V. Pérez-Gallardo, R. Noriega-Cisneros, E. Esquivel-Gutiérrez et al., “Effects of diabetes on oxidative and nitrosative stress in kidney mitochondria from aged rats,” Journal of Bioenergetics and Biomembranes, vol. 46, no. 6, pp. 511–518, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. H. G. M. Willems, R. Rossignol, C. E. J. Dieteren, M. P. Murphy, and W. J. H. Koopman, “Redox homeostasis and mitochondrial dynamics,” Cell Metabolism, vol. 22, no. 2, pp. 207–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Chen and D. C. Chan, “Emerging functions of mammalian mitochondrial fusion and fission,” Human Molecular Genetics, vol. 14, Supplement 2, pp. R283–R289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Cho, T. Nakamura, J. Fang et al., “S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury,” Science, vol. 324, no. 5923, pp. 102–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. P. Leboucher, Y. C. Tsai, M. Yang et al., “Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis,” Molecular Cell, vol. 47, no. 4, pp. 547–557, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Sacksteder, W. J. Qian, T. V. Knyushko et al., “Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease,” Biochemistry, vol. 45, no. 26, pp. 8009–8022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Qiang, K. Weiqiang, Z. Qing, Z. Pengju, and L. Yi, “Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKα,” Experimental & Molecular Medicine, vol. 39, no. 4, pp. 535–543, 2007. View at Publisher · View at Google Scholar
  16. R. M. Reznick, H. Zong, J. Li et al., “Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis,” Cell Metabolism, vol. 5, no. 2, pp. 151–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Y. Seo, A. M. Joseph, D. Dutta, J. C. Y. Hwang, J. P. Aris, and C. Leeuwenburgh, “New insights into the role of mitochondria in aging: mitochondrial dynamics and more,” Journal of Cell Science, vol. 123, no. 15, pp. 2533–2542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. L. Puri and V. Sartorelli, “HDACs and sirtuins: targets for new pharmacological interventions in human diseases,” Pharmacological Research, vol. 62, no. 1, pp. 1-2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Kincaid and E. Bossy-Wetzel, “Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration,” Frontiers in Aging Neuroscience, vol. 5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Schwer, M. Eckersdorff, Y. Li et al., “Calorie restriction alters mitochondrial protein acetylation,” Aging Cell, vol. 8, no. 5, pp. 604–606, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. W. C. Hallows, W. Yu, B. C. Smith et al., “Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction,” Molecular Cell, vol. 41, no. 2, pp. 139–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Shi, F. Wang, E. Stieren, and Q. Tong, “SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes,” Journal of Biological Chemistry, vol. 280, no. 14, pp. 13560–13567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Qiu, K. Brown, M. D. Hirschey, E. Verdin, and D. Chen, “Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation,” Cell Metabolism, vol. 12, no. 6, pp. 662–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. D. B. Lombard, F. W. Alt, H. L. Cheng et al., “Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation,” Molecular and Cellular Biology, vol. 27, no. 24, pp. 8807–8814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Schwer, J. Bunkenborg, R. O. Verdin, J. S. Andersen, and E. Verdin, “Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10224–10229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. W. C. Hallows, S. Lee, and J. M. Denu, “Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10230–10235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Kong, R. Wang, Y. Xue et al., “Sirtuin 3, a new target of PGC-1α, plays an important role in the suppression of ROS and mitochondrial biogenesis,” PloS One, vol. 5, no. 7, article e11707, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. A. Samant, H. J. Zhang, Z. Hong et al., “SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress,” Molecular and Cellular Biology, vol. 34, no. 5, pp. 807–819, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Raffaello and R. Rizzuto, “Mitochondrial longevity pathways,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1813, no. 1, pp. 260–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. G. Pelicci, “Electron transfer between cytochrome C and p66SHC generates reactive oxygen species that trigger mitochondrial apoptosis,” The FEBS Journal, vol. 272, Supplement 1, pp. 319-320, 2005. View at Google Scholar
  31. A. Boveris, N. Oshino, and B. Chance, “The cellular production of hydrogen peroxide,” Biochemical Journal, vol. 128, no. 3, pp. 617–630, 1972. View at Publisher · View at Google Scholar
  32. E. Migliaccio, M. Giorgio, S. Mele, and G. Pelicci, “The p66Shc adaptor protein controls oxidative stress response and life span in mammals,” Nature, vol. 402, no. 6759, pp. 309–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Berniakovich, M. Trinei, M. Stendardo et al., “p66Shc-generated oxidative signal promotes fat accumulation,” Journal of Biological Chemistry, vol. 283, no. 49, pp. 34283–34293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Berry, A. Greco, M. Giorgio et al., “Deletion of the lifespan determinant p66Shc improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice,” Experimental Gerontology, vol. 43, no. 3, pp. 200–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Giulivi, J. J. Poderoso, and A. Boveris, “Production of nitric oxide by mitochondria,” Journal of Biological Chemistry, vol. 273, no. 18, pp. 11038–11043, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. R. G. Knowles and M. Salter, “Measurement of NOS activity by conversion of radiolabeled arginine to citrulline using ion-exchange separation,” Nitric Oxide Protocols, vol. 100, pp. 67–73, 1998. View at Publisher · View at Google Scholar
  37. M. C. Carreras, M. Melani, N. Riobó, D. P. Converso, E. M. Gatto, and J. J. Poderoso, “Neuronal nitric oxide synthases in brain and extraneural tissues,” Methods in Enzymology, vol. 359, pp. 413–423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. M. C. Carreras, D. P. Converso, A. S. Lorenti et al., “Mitochondrial nitric oxide synthase drives redox signals for proliferation and quiescence in rat liver development,” Hepatology, vol. 40, no. 1, pp. 157–166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. McCord and I. Fridovich, “The utility of superoxide dismutase in studying free radical reactions I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen,” Journal of Biological Chemistry, vol. 244, no. 22, pp. 6056–6063, 1969. View at Google Scholar
  40. B. Chance, “Special methods: catalase,” Methods of Biochemical Analysis, R. Glick, Ed., Wiley Interscience, New York, NY, USA, 1954. View at Google Scholar
  41. R. W. Estabrook, “[7] Mitochondrial respiratory control and the polarographic measurement of ADP: O ratios,” Methods in Enzymology, vol. 10, pp. 41–47, 1967. View at Publisher · View at Google Scholar · View at Scopus
  42. M. C. Carreras, J. G. Peralta, D. P. Converso et al., “Modulation of liver mitochondrial NOS is implicated in thyroid-dependent regulation of O2 uptake,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 281, no. 6, pp. H2282–H2288, 2001. View at Publisher · View at Google Scholar
  43. S. M. Cardoso, C. Pereira, and C. R. Oliveira, “Mitochondrial function is differentially affected upon oxidative stress,” Free Radical Biology & Medicine, vol. 26, no. 1-2, pp. 3–13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Schwer, B. J. North, R. A. Frye, M. Ott, and E. Verdin, “The human silent information regulator (Sir) 2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide–dependent deacetylase,” The Journal of Cell Biology, vol. 158, no. 4, pp. 647–657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. S. Gonzalez, M. E. Elguero, P. Finocchietto et al., “Abnormal mitochondrial fusion–fission balance contributes to the progression of experimental sepsis,” Free Radical Research, vol. 48, no. 7, pp. 769–783, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Venegas, J. Wang, D. Dimmock, and L. J. Wong, “Real-time quantitative PCR analysis of mitochondrial DNA content,” Current Protocols in Human Genetics, vol. 68, pp. 19.7:19.7.1–19.7:19.7.12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. J. P. Sánchez-Villamil, V. D’Annunzio, P. Finocchietto et al., “Cardiac-specific overexpression of thioredoxin 1 attenuates mitochondrial and myocardial dysfunction in septic mice,” The International Journal of Biochemistry & Cell Biology, vol. 81, Part B, pp. 323–334, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Gonzalez-Freire, R. De Cabo, M. Bernier et al., “Reconsidering the role of mitochondria in aging,” The Journals of Gerontology: Series A, vol. 70, no. 11, pp. 1334–1342, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Pérez, M. E. Elguero, N. M. Villalba, Y. Alippe, J. J. Poderoso, and M. C. Carreras, “P66shc and its role in mitochondrial homeostasis throughout the aging process,” Medicina, vol. 76, Supplement 1, p. 105, 2016. View at Google Scholar
  50. K. Sone, M. Mori, and N. Mori, “Selective upregulation of p66-Shc gene expression in the liver and brain of aged rats,” Archives of Gerontology and Geriatrics, vol. 55, no. 3, pp. 744–748, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Nisoli, C. Tonello, A. Cardile et al., “Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS,” Science, vol. 310, no. 5746, pp. 314–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. M. C. Carreras and J. J. Poderoso, “Mitochondrial nitric oxide in the signaling of cell integrated responses,” American Journal of Physiology-Cell Physiology, vol. 292, no. 5, pp. C1569–C1580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Francia, C. delli Gatti, M. Bachschmid et al., “Deletion of p66Shc gene protects against age-related endothelial dysfunction,” Circulation, vol. 110, no. 18, pp. 2889–2895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Lizana, B. Bauer, and O. Orwar, “Controlling the rates of biochemical reactions and signaling networks by shape and volume changes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4099–4104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. C. A. Mannella, W. J. Lederer, and M. S. Jafri, “The connection between inner membrane topology and mitochondrial function,” Journal of Molecular and Cellular Cardiology, vol. 62, pp. 51–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. J. E. Telford, S. M. Kilbride, and G. P. Davey, “Complex I is rate-limiting for oxygen consumption in the nerve terminal,” Journal of Biological Chemistry, vol. 284, no. 14, pp. 9109–9114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Rose, S. Dato, K. Altomare et al., “Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly,” Experimental Gerontology, vol. 38, no. 10, pp. 1065–1070, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Halaschek-Wiener, M. Amirabbasi-Beik, N. Monfared et al., “Genetic variation in healthy oldest-old,” PLoS One, vol. 4, no. 8, article e6641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. S. J. Allison and J. Milner, “SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways,” Cell Cycle, vol. 6, no. 21, pp. 2669–2677, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Gounden, A. Phulukdaree, D. Moodley, and A. Chuturgoon, “Increased SIRT3 expression and antioxidant defense under hyperglycemic conditions in HepG2 cells,” Metabolic Syndrome and Related Disorders, vol. 13, no. 6, pp. 255–263, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. K. R. Short, M. L. Bigelow, J. Kahl et al., “Decline in skeletal muscle mitochondrial function with aging in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 15, pp. 5618–5623, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Koltai, N. Hart, A. W. Taylor et al., “Age-associated declines in mitochondrial biogenesis and protein quality control factors are minimized by exercise training,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 303, no. 2, pp. R127–R134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. D. A. Chistiakov, I. A. Sobenin, V. V. Revin, A. N. Orekhov, and Y. V. Bobryshev, “Mitochondrial aging and age-related dysfunction of mitochondria,” BioMed Research International, vol. 2014, Article ID 238463, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Fan, R. Hussien, and G. A. Brooks, “H2O2-induced mitochondrial fragmentation in C2C12 myocytes,” Free Radical Biology & Medicine, vol. 49, no. 11, pp. 1646–1654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Taguchi, N. Ishihara, A. Jofuku, T. Oka, and K. Mihara, “Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission,” Journal of Biological Chemistry, vol. 282, no. 15, pp. 11521–11529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. Z. Liu, J. Cao, Q. Ma, X. Gao, J. Ren, and Y. Xue, “GPS-YNO2: computational prediction of tyrosine nitration sites in proteins,” Molecular BioSystems, vol. 7, no. 4, pp. 1197–1204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. A. P. Gomes, N. L. Price, A. J. Y. Ling et al., “Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging,” Cell, vol. 155, no. 7, pp. 1624–1638, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. I. B. Afanas’ev, “Free radical mechanisms of aging processes under physiological conditions,” Biogerontology, vol. 6, no. 4, pp. 283–290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. L. T. Knapp and E. Klann, “Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content,” Journal of Biological Chemistry, vol. 275, no. 31, pp. 24136–24145, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Ikeyama, G. Kokkonen, S. Shack, X. T. Wang, and N. J. Holbrook, “Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities,” The FASEB Journal, vol. 16, no. 1, pp. 114–116, 2002. View at Publisher · View at Google Scholar
  71. Q. Jin, B. S. Jhun, S. H. Lee et al., “Differential regulation of phosphatidylinositol 3-kinase/Akt, mitogen-activated protein kinase, and AMP-activated protein kinase pathways during menadione-induced oxidative stress in the kidney of young and old rats,” Biochemical and Biophysical Research Communications, vol. 315, no. 3, pp. 555–561, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. S. L. Colombo and S. Moncada, “AMPKα1 regulates the antioxidant status of vascular endothelial cells,” Biochemical Journal, vol. 421, no. 2, pp. 163–169, 2009. View at Publisher · View at Google Scholar · View at Scopus